BioMérieux S.A.
BIM
Peringkat dalam Saham
#1851
bioMérieux S.A. is a global entity operating across the Americas, Europe, the... bioMérieux S.A. is a global entity operating across the Americas, Europe, the Middle East, Africa, and the Asia Pacific, specializing in the development and production of in vitro diagnostic solutions. The company's sophisticated systems utilize biological samples to identify infectious diseases, cardiovascular conditions, and various forms of cancer. Additionally, bioMérieux provides essential microbiological testing services for the manufacturing sectors, primarily serving the food, pharmaceutical, cosmetics, and veterinary industries. Its client base includes clinical and hospital laboratories, medical practitioners, blood banks, and industrial quality control facilities. Founded in 1963, originally under the name B-D Mérieux, bioMérieux S.A. maintains its headquarters in Marcy l'Etoile, France, and functions as a subsidiary of Institut Mérieux SA.
Harga Saham
$97.31
Kapitalisasi Pasar
$11.45B
Perubahan (1 hari)
-5.92%
Perubahan (1 tahun)
-23.81%
Negara
FR
Perdagangan BioMérieux S.A. (BIM)
Kategori
Healthcare
Pendapatan untuk BioMérieux S.A. (BIM)
Pendapatan pada Jun 2026 TTM: $4.73B
Menurut laporan keuangan terbaru dari BioMérieux S.A., pendapatan saat ini (TTM) adalah $4.73B. Pada tahun 2023, perusahaan menghasilkan pendapatan sebesar $4.06B peningkatan dibandingkan pendapatan pada tahun 2022 yang sebesar $3.85B. Pendapatan adalah jumlah total yang dihasilkan dari penjualan barang atau jasa. Tidak seperti laba, tidak ada pengeluaran yang dikurangkan.
Riwayat pendapatan BioMérieux S.A. dari 2005 hingga 2026
Pendapatan pada akhir setiap tahun
| Tahun | Pendapatan | Mengubah |
|---|---|---|
| 2026 (TTM) | $4.73B | 14.30% |
| 2024 | $4.14B | 1.95% |
| 2023 | $4.06B | 5.51% |
| 2022 | $3.85B | 0.28% |
| 2021 | $3.84B | 1.10% |
| 2020 | $3.80B | 26.54% |
| 2019 | $3.00B | 7.86% |
| 2018 | $2.78B | 1.34% |
| 2017 | $2.75B | 24.07% |
| 2016 | $2.21B | 3.74% |
| 2015 | $2.13B | 3.81% |
| 2014 | $2.05B | -5.89% |
| 2013 | $2.18B | 5.45% |
| 2012 | $2.07B | 12.08% |
| 2011 | $1.85B | 1.83% |
| 2010 | $1.81B | 3.43% |
| 2009 | $1.75B | 13.35% |
| 2008 | $1.55B | -0.38% |
| 2007 | $1.55B | 13.87% |
| 2006 | $1.36B | 16.21% |
| 2005 | $1.17B | 0.00% |
Pendapatan untuk perusahaan serupa atau pesaing
| Perusahaan | Pendapatan | Perbedaan Pendapatan | Negara |
|---|---|---|---|
| $46.34B | 878.90% |
US
|
|
| $25.11B | 430.41% |
US
|
|
| $2.71B | -42.81% |
US
|
|
| - | - |
CN
|
|
| $7.37B | 55.74% |
US
|
